Impact of diabetes mellitus on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty: Analysis from the HORIZONS-AMI (Harmonizing outcomes with revasculariZatiON and stents in acute myocardial infarction) trial

JACC: Cardiovascular Interventions

Volumn 4, Issue 7, 2011, Pages 760-768

  Witzenbichler, Bernhard ^a   Mehran, Roxana ^g   Guagliumi, Giulio ^b   Dudek, Dariusz ^c   Huber, Kurt ^d   Kornowski, Ran ^e   Stuckey, Thomas D ^f   Fahy, Martin ^g   Parise, Helen ^g   Stone, Gregg W ^g  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b OSPEDALI RIUNITI   (Italy)

^c JAGIELLONIAN UNIVERSITY   (Poland)

^d WILHELMINEN HOSPITAL   (Austria)

^e RABIN MEDICAL CENTER   (Israel)

^f MOSES H CONE MEMORIAL HOSPITAL   (United States)

^g NewYork Presbyterian Hospital   (United States)

Author keywords

diabetes mellitus; major adverse cardiac event(s); primary percutaneous coronary intervention; ST segment elevation myocardial infarction; stent thrombosis

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; INSULIN;

ADULT; AGED; ANGIOPLASTY; ARTICLE; BLEEDING; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART DEATH; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT; STENT THROMBOSIS; STROKE; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTITHROMBINS; CORONARY ANGIOGRAPHY; DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HIRUDINS; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; STENTS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79960603166     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2011.04.008     Document Type: Article

References (32)

1. M. Roffi, and E.J. Topol Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromes Eur Heart J 25 2004 190 198 (Pubitemid 38235154)
2. G. De Luca, C.M. Gibson, and F. Bellandi Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb-IIIa inhibitors Atherosclerosis 207 2009 181 185
3. D.L. Bhatt, S.P. Marso, and A.M. Lincoff Abciximab reduces mortality in diabetics following percutaneous coronary intervention J Am Coll Cardiol 35 2000 922 928 (Pubitemid 30189923)
4. S.P. Marso, A.M. Lincoff, and S.G. Ellis Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy Circulation 100 1999 2477 2484 (Pubitemid 30005110)
5. P. Theroux, J. Alexander Jr., and C. Pharand Glycoprotein IIb/IIIa receptor blockade improves outcomes in diabetic patients presenting with unstable angina/non-ST-elevation myocardial infarction: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) study Circulation 102 2000 2466 2472
6. G. Montalescot, P. Barragan, and O. Wittenberg Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction N Engl J Med 344 2001 1895 1903 (Pubitemid 32553358)
7. F.G. Kushner, M. Hand, and S.C. Smith Jr. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 54 2009 2205 2241
8. J. Mehilli, A. Kastrati, and S. Schulz Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial Circulation 119 2009 1933 1940
9. A.M. Lincoff, J.A. Bittl, and R.A. Harrington Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial JAMA 289 2003 853 863 (Pubitemid 37430344)
10. G.W. Stone, B.T. McLaurin, and D.A. Cox Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 2006 2203 2216 (Pubitemid 44791162)
11. G.W. Stone, B. Witzenbichler, and G. Guagliumi Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230 (Pubitemid 351724451)
12. R. Mehran, B. Brodie, and D.A. Cox The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale Am Heart J 156 2008 44 56 (Pubitemid 351862292)
13. G.W. Stone, A.J. Lansky, and S.J. Pocock Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction N Engl J Med 360 2009 1946 1959
14. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
15. S.M. Haffner, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 1998 229 234 (Pubitemid 28350165)
16. K.J. Harjai, G.W. Stone, and J. Boura Comparison of outcomes of diabetic and nondiabetic patients undergoing primary angioplasty for acute myocardial infarction Am J Cardiol 91 2003 1041 1045 (Pubitemid 36514916)
17. K.H. Mak, D.J. Moliterno, C.B. Granger GUSTO-I Investigators Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction Global Utilization of streptokinase and tissue plasminogen activator for Occluded Coronary arteries J Am Coll Cardiol 30 1997 171 179 (Pubitemid 27357143)
18. A. Prasad, G.W. Stone, and T.D. Stuckey Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction J Am Coll Cardiol 45 2005 508 514 (Pubitemid 40222243)
19. J.R. Timmer, I.C. van der Horst, and G. de Luca Comparison of myocardial perfusion after successful primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction with versus without diabetes mellitus Am J Cardiol 95 2005 1375 1377 (Pubitemid 40719874)
20. G. De Luca, H. Suryapranata, and G.W. Stone Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials JAMA 293 2005 1759 1765
21. F.J. Neumann, R. Blasini, and C. Schmitt Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction Circulation 98 1998 2695 2701 (Pubitemid 28564004)
22. G.W. Stone, C.L. Grines, and D.A. Cox Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction N Engl J Med 346 2002 957 966 (Pubitemid 34983245)
23. T.D. Stuckey, G.W. Stone, and D.A. Cox Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC trial) Am J Cardiol 95 2005 1 7 (Pubitemid 40051103)
24. F.J. Neumann, A. Kastrati, and C. Schmitt Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction J Am Coll Cardiol 35 2000 915 921 (Pubitemid 30189922)
25. D. Antoniucci, A. Rodriguez, and A. Hempel A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction J Am Coll Cardiol 42 2003 1879 1885 (Pubitemid 37485558)
26. G. Montalescot, D. Antoniucci, and A. Kastrati Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up Eur Heart J 28 2007 443 449 (Pubitemid 47343560)
27. R. Mehran, A.J. Lansky, and B. Witzenbichler Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial Lancet 374 2009 1149 1159
28. G. De Luca, E. Navarese, and P. Marino Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials Eur Heart J 30 2009 2705 2713
29. A.V. Hernandez, E. Boersma, G.D. Murray, J.D. Habbema, and E.W. Steyerberg Subgroup analyses in therapeutic cardiovascular clinical trials: are most of them misleading? Am Heart J 151 2006 257 264 (Pubitemid 43148981)
30. I. Akin, A. Bufe, and S. Schneider Clinical outcomes in diabetic and non-diabetic patients with drug-eluting stents: results from the first phase of the prospective multicenter German DES.DE registry Clin Res Cardiol 99 2010 393 400
31. J. Aoki, A.J. Lansky, and R. Mehran Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial Circulation 119 2009 687 698
32. G. De Luca, C. Michael-Gibson, and F. Bellandi Benefits of pharmacological facilitation with glycoprotein IIb-IIIa inhibitors in diabetic patients undergoing primary angioplasty for STEMI A subanalysis of the EGYPT cooperation J Thromb Thrombolysis 28 2009 288 298